Clinical efficiency and tolerance of hydrogen sulfide balneotherapy in hypertensive patients living in the climate of arid zone

Terapevticheskii Arkhiv

Volumn 75, Issue 8, 2003, Pages 32-35

  Zunnunov, Z R ^a  

^a NONE

Author keywords

24 h monitoring of blood pressure; Essential hypertension; Hot climate; Hydrogen sulfide balneotherapy; Treatment

Indexed keywords

HYDROGEN SULFIDE;

ADULT; AGED; ARTICLE; BATH; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; DESERT CLIMATE; FEMALE; HOSPITALIZATION; HUMAN; HYPERTENSION; MALE; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; TREATMENT OUTCOME; UZBEKISTAN;

ADULT; AGED; BATHS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; DESERT CLIMATE; FEMALE; HUMANS; HYDROGEN SULFIDE; HYPERTENSION; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; UZBEKISTAN;

EID: 1542599989     PISSN: 00403660     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Sheehy O., Le Lorier J. Patterns of amlodipine and felodipine use in an elderly Quebec population. Can. J. Cardiol. 2000; 16: 1109-1117.
2. Hansson L., Zanchetti A., Carruthers S. G. et al for the HOT Study Group. Effects of intensive blood presure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998; 351: 1755-1762.
3. Satura T. Current status of calcium antagonists in Japan. Am. J. Cardiol. 1998; 82: 32R-34R.
4. 1999 World Health Organization - International Society of Hypertension Guidelines for the Management of Hypertension. J. Hypertens. 1999; 17: 151-183.
5. Digiesi V., Fiorillo C., Cosmi L. et al. Reactive oxygen species and antioxidant status in essential arterial hypertension during therapy with dihydropyridine calcium channel antagonists. Clin. Ther. 2000; 151: 15-18.
6. Goyal R. K. Hyperinsulinemia and insulin resistance in hypertension: differential effects of antihypertensive agents. Clin. Exp. Hypertens. 1999; 21: 167-179.
7. Hansson L., Lindholm L. H., Niskanen L. et al for the Captopril Prevention Prohect (CAPP) study group. Effect of angiotensin - converting - enzyme inhibition compared with convertional therapy on cardiovascular morbidity and mortality in hypertension. Lancet 1999; 353: 611-616.
8. Britten M. B., Zeiher A. M., Schachinger V. Clinical importanse of coronary endothelial vasodilator dysfunction and therapeutic options. J. Intern. Med. 1999. 245: 315-327.